Mutations in five PARK genes (SNCA, PARKIN, DJ-1, PINK1, and LRRK2) are well-established genetic causes of Parkinson disease (PD). Recently, G2385R substitution in LRRK2 has been determined as a susceptibility allele in Asian PD. The objective of this study is to determine the frequency of mutations in these PARK genes in a Korean early-onset Parkinson disease (EOPD) cohort. The authors sequenced 35 exons in SNCA, PARKIN, DJ-1, PINK1, and LRRK2 in 72 unrelated EOPD (age-at-onset ≤50) recruited from ten movement disorders clinics in South Korea. Gene dosage change of the aforementioned genes was studied using multiple ligation-dependent probe amplification. We found four patients with PARKIN mutations, which were homozygous deletion of exon 4, compound heterozygous deletion of exon 2 and exon 4, heterozygous deletion of exon 4, and heterozygous nonsense mutation (Q40X). Four patients had PINK1 mutations; a compound heterozygous mutation (N367S and K520RfsX522) and three heterozygous mutations (G32R, R279H, and F385L). A missense mutation of SNCA (A53T) was found in a familial PD with autosomal dominant inheritance. Nine patients (12.5%) had heterozygous G2385R polymorphism of LRRK2, whereas none had G2019S mutation. However, no mutations were detected in DJ-1 and UCHL1 in our series. We identified genetic variants in PARKIN, PINK1, LRRK2, and SNCA as a cause or genetic risk factors for PD in 25% of Korean EOPD, and mutation of PARKIN was the most common genetic cause.
Parkinson disease Genetics of Parkinson disease Mutation of Mendelian genes Susceptibility genes of Parkinson disease Early-onset Parkinson disease
This is a preview of subscription content, log in to check access.
This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2005-042-E00123).
Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC et al (2004) Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson’s disease. Clin Genet 65:209–214 doi:10.1111/j.0009-9163.2004.00213.xPubMedCrossRefGoogle Scholar
Bras J, Guerreiro R, Ribeiro M, Morgadinho A, Januario C, Dias M et al (2008) Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2. BMC Neurol 8:1 doi:10.1186/1471-2377-8-1PubMedCrossRefGoogle Scholar
Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57:1497–1499PubMedGoogle Scholar
Choi JM, Woo MS, Kim SM, Ma HI, Sung YH, Lee PH et al (2008) Trinucleotide repeats number in SCA2, SCA3 and SCA17 in early-onset Parkinson’s disease. J Korean Neurol Assoc 26:23–27Google Scholar
Djarmati A, Guzvic M, Grunewald A, Lang AE, Pramstaller PP, Simon DK et al (2007) Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification. Mov Disord 22:1708–1714 doi:10.1002/mds.21370PubMedCrossRefGoogle Scholar
Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S et al (2007) Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson’s disease gene rearrangements. Mov Disord 22:2274–2278 doi:10.1002/mds.21532PubMedCrossRefGoogle Scholar
Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohe CF et al (2006) A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan. Neurogenetics 7:133–138 doi:10.1007/s10048-006-0041-5PubMedCrossRefGoogle Scholar
Djarmati A, Hedrich K, Svetel M, Schafer N, Juric V, Vukosavic S et al (2004) Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients. Hum Mutat 23:525 doi:10.1002/humu.9240PubMedCrossRefGoogle Scholar
Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H et al (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44:935–941 doi:10.1002/ana.410440612PubMedCrossRefGoogle Scholar
Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J et al (2004) Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 19:1146–1157 doi:10.1002/mds.20234PubMedCrossRefGoogle Scholar
Hedrich K, Hagenah J, Djarmati A, Hiller A, Lohnau T, Lasek K et al (2006) Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? Arch Neurol 63:833–838 doi:10.1001/archneur.63.6.833PubMedCrossRefGoogle Scholar
Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J et al (2007) Heterozygous parkin point mutations are as common in control subjects as in Parkinson’s patients. Ann Neurol 61:47–54 doi:10.1002/ana.21039PubMedCrossRefGoogle Scholar
Hedrich K, Kann M, Lanthaler AJ, Dalski A, Eskelson C, Landt O et al (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10:1649–1656 doi:10.1093/hmg/10.16.1649PubMedCrossRefGoogle Scholar
Cho JW, Kim SY, Park SS, Kim HJ, Ahn TB, Kim JM et al (2007) The G2019S LRRK2 mutation is rare in Korean patients with Parkinson’s disease. Can J Neurol Sci 34:53–55PubMedGoogle Scholar
Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H et al (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 57:918–921 doi:10.1002/ana.20484PubMedCrossRefGoogle Scholar